Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 2
2022 2
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean kabel c c[au] (4 results)?
Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection.
Harvey RA, Rassen JA, Kabelac CA, Turenne W, Leonard S, Klesh R, Meyer WA 3rd, Kaufman HW, Anderson S, Cohen O, Petkov VI, Cronin KA, Van Dyke AL, Lowy DR, Sharpless NE, Penberthy LT. Harvey RA, et al. Among authors: kabelac ca. JAMA Intern Med. 2021 May 1;181(5):672-679. doi: 10.1001/jamainternmed.2021.0366. JAMA Intern Med. 2021. PMID: 33625463 Free PMC article.
Real-world performance of SARS-Cov-2 serology tests in the United States, 2020.
Rodriguez-Watson CV, Louder AM, Kabelac C, Frederick CM, Sheils NE, Eldridge EH, Lin ND, Pollock BD, Gatz JL, Grannis SJ, Vashisht R, Ghauri K, Knepper C, Leonard S, Embi PJ, Jenkinson G, Klesh R, Garner OB, Patel A, Dahm L, Barin A, Cooper DM, Andriola T, Byington CL, Crews BO, Butte AJ, Allen J. Rodriguez-Watson CV, et al. Among authors: kabelac c. PLoS One. 2023 Feb 3;18(2):e0279956. doi: 10.1371/journal.pone.0279956. eCollection 2023. PLoS One. 2023. PMID: 36735683 Free PMC article.
Duration of Protection Against SARS-CoV-2 Reinfection and Associated Risk of Reinfection Assessed with Real-World Data.
Reynolds SL, Kaufman HW, Meyer WA, Bush C, Cohen O, Cronin K, Kabelac C, Leonard S, Anderson S, Petkov V, Lowy D, Sharpless N, Penberthy L. Reynolds SL, et al. Among authors: kabelac c. medRxiv [Preprint]. 2022 Feb 26:2022.02.25.22271515. doi: 10.1101/2022.02.25.22271515. medRxiv. 2022. PMID: 35233580 Free PMC article. Updated. Preprint.
Real-world utilization of SARS-CoV-2 serological testing in RNA positive patients across the United States.
Rodriguez-Watson CV, Sheils NE, Louder AM, Eldridge EH, Lin ND, Pollock BD, Gatz JL, Grannis SJ, Vashisht R, Ghauri K, Valo G, Chakravarty AG, Lasky T, Jung M, Lovell SL, Major JM, Kabelac C, Knepper C, Leonard S, Embi PJ, Jenkinson WG, Klesh R, Garner OB, Patel A, Dahm L, Barin A, Cooper DM, Andriola T, Byington CL, Crews BO, Butte AJ, Allen J. Rodriguez-Watson CV, et al. Among authors: kabelac c. PLoS One. 2023 Feb 10;18(2):e0281365. doi: 10.1371/journal.pone.0281365. eCollection 2023. PLoS One. 2023. PMID: 36763574 Free PMC article.
Real-world data suggest antibody positivity to SARS-CoV-2 is associated with a decreased risk of future infection.
Harvey RA, Rassen JA, Kabelac CA, Turenne W, Leonard S, Klesh R, Meyer WA 3rd, Kaufman HW, Anderson S, Cohen O, Petkov VI, Cronin KA, Van Dyke AL, Lowy DR, Sharpless NE, Penberthy LT. Harvey RA, et al. Among authors: kabelac ca. medRxiv [Preprint]. 2020 Dec 20:2020.12.18.20248336. doi: 10.1101/2020.12.18.20248336. medRxiv. 2020. PMID: 33354682 Free PMC article. Updated. Preprint.